INTRODUCTION
Resistance to thyroid hormone (RTH) is a syndrome characterized by refractoriness of the pituitary and peripheral tissues to the action of thyroid hormone and is usually transmitted in an R. Wong et al.: Influence of Cell Type on Dominant Negative Potency of Mutant T3 Receptors 307 of h-TR,Bl for its ligand, 3,3',5-triiodothyronine (T3), and impaired transcriptional capacity (4, 5) . The mutant h-TRf3I inhibits the function of normal h-TR,1 and al via a dominant negative effect, thereby mediating the abnormal phenotype (6) (7) (8) (9) . Kindreds with RTH display a remarkable heterogeneity in organ resistance within an individual and among kindreds harboring identical mutations (10) , and there are ongoing attempts to correlate genotype with the phenotype of these patients.
The difficulty in establishing such correlations stems from the complex molecular nature of the interactions of the thyroid hormone receptor. Not only are there four isoforms of the thyroid hormone receptor, which are expressed in a tissue-specific and development-stage-specific manner, but they may also heterodimerize with multiple cellular partners, most prominently the retinoid X-receptors (RXRs), to create unique transcriptional responses of T3-regulated genes (11) (12) (13) (14) (15) (16) . Published examples of genotype-phenotype correlations include an association between language abnormalities with mutations in exon 9 (17) , and a high ratio of mutant:normal h-TR,3 mRNA during a period of bone resistance with growth retardation, attenuated in teenage years with a concomitant improvement in growth rate (18) . In general, however, neither the T3-binding impairment of h-TRI3 mutants, as reflected by blood levels of thyroid hormones, nor the location of mutations predicts a phenotype.
Until recently, studies of mutant h-TRfI have employed mostly artificial thyroid response elements (TREs) (7, (19) (20) (21) . Moreover, there has not been a systematic comparison of the effects of mutant h-TR,Bl on various natural positive TREs in different cell types. Furthermore, there have been conflicting data regarding the relative roles of heterodimers versus homodimers in mediating the dominant negative effect of these mutant receptors (22, 23) . These studies have employed transfections in a single cell type, utilizing mostly artificial TREs and exogenous RXRs to characterize the nature of protein-protein complexes. We were interested in determining the extent to which the cellular environment contributes to the dominant negative action of mutant receptors. Thus, we performed transient transfection assays using naturally occurring TREs in two different cell lines, HeLa and NIH3T3, and gel-shift studies using these nuclear extracts to establish if there are differences in protein-protein interactions. These proteins may include those that interact either directly with mutant h-TR,Bl, so called thyroid hormone receptor auxiliary proteins (TRAPs), or indirectly to bring the TR-complex into contact with the transcriptional machinery, so called adaptor or coactivator proteins (24) . Our results demonstrated that the extent of the transactivation by wild-type (WT) h-TRl31 on the three natural TREs studied is different in the two cell types and that the three mutant receptors display different dominant negative potencies in the two cell types despite equivalent expression levels of receptor in these cells, as demonstrated by immunocytochemistry. Furthermore, the pattern of hetero-and homodimerization differs when nuclear extracts from these two cell types are used in gel-shift studies. The cell type in which the mutant receptors act, together with the type of TRE motif, most probably determines the patterns of hetero-and homodimerization of these receptors, the relative abundance of which, in turn, contributes to the strength of their dominant negative effect.
MATERIALS AND METHODS

Construction of Plasmids
Construction of the WT h-TR,B1 and mutant pSV2 expression vectors -ED, -OK, and -PV, and the corresponding pGEM 3Z-vectors for in vitro translation has been described before (19, 20, 25) . The TK-TRE constructs, -Lys, -ME, and -GH, were a kind gift of Dr. G. Brent, Harvard Medical School, Boston, MA, U.S.A.; the construction of these has been described previously (26 (27) , 100 p/ml penicillin, 100 jig/ml streptomycin and 0.25 ,ll/ml amphotericin B in 10-cm petri dishes. The medium was changed 4 hr prior to transfection. Transfections were performed in pairs (CellPhect kit; Pharmacia-LKB, Piscataway, NJ, U.S.A.) using the CaPO4 method. Each plate received 5.0 ,ug TREcontaining TK-CAT plasmid, 3 .0 jig pXGH5 plasmid as a transfection efficiency control, 1.0 jig pSV2-WT h-TR31, 0-5.0 ,ug mutant h-TRf3l, and 0-5.0 ,ug pSV2 to keep the amount of transfected DNA constant. After 24 hr, the plates were washed once with phosphate-buffered saline and fresh medium added together with the appropriate T3 concentration. CAT assays were performed 24 hr later, after harvesting and lysing the cells, as previously described (28) . CAT 
RESULTS
The characteristics of the h-TRJ31 mutants (5) are shown in Table 1 . ED and OK have point mutations leading to reduced T3-binding affinities and reduced transcriptional capacities; PV has a frameshift mutation at the carboxy-termninus which abolishes both T3-binding activity and transcrip- transactivated by T3 in HeLa cells but in 3T3 cells a dominant negative effect occurred, again representing a significant difference between the cell types. Figure 5 shows the dominant negative effect of mutant PV in the two cell types. On the Figure 7A and B shows binding of the OK mutant to the Lys-and ME-TREs, respectively. The pattern of heterodimerization on the Lys-TRE in HeLa cells is identical to that for WT h-TRf3I (Fig. 6A) . There was specific competition of both heterodimer bands by the unlabeled probe (Lane 6). In the case of the 3T3 nuclear extract, however, prominent homodimer bands were seen, together with a much weaker upper heterodimer band (Lane 9). Both bands represent specific interactions of the mutant h-TR,Bl with factors in the nuclear extract, which disappear upon addition of unlabeled probe in lane 10. Using the ME-TRE in HeLa cells, prominent heterodimers formed when either the WT h-TR,B1 or mutant receptors were used (Fig. 6B , Lane 5 versus Fig. 7B , Lane 5) . No homodimers were seen using either HeLa or 3T3 nuclear extract on the ME-TRE. In 3T3 cells, upper heterodimers of weaker intensities formed when either WT or mutant h-TRl3 were used (Fig. 6B , Lane 9 versus Fig. 7B, Lane 9 ). Thus, depending on the cell type and the TRE, both mutant hetero-and homodimers may contribute to the dominant negative activities of mutant receptors. Our findings also suggested that on the identical TRE, the same mutation could mediate varying strengths of dominant negative inhibition depending on whether homodimers or heterodimers form. It could further be postulated that, since transactivation is thought to occur mostly via the stable heterodimer, the greater the ability to form heterodimers, the less potent the dominant negative effect of a mutant receptor will be. Since h-TR,Bl was only able to form heterodimers on the ME-TRE, the dominant negative potencies of mutant receptors on this element could be predicted to be less than on the A. Lys B.ME HeLa NIH3T3 1 2 3 4 5 6 7 8 9 10 Heterodimer--w Gel mobility analyses using nuclear extracts from HeLa cells and NIH3T3 cells with mutant receptor OK on the (A) Lys-and (B) ME-TREs Experimental conditions were identical to those for Fig. 6 . In this case, however, both gels were exposed for 14 hr. There is a nonspecific band (NS) that runs just a little above the homodimer band in the panel with HeLa nuclear extract and again, as in Fig. 6A , is not competed away by specific competitor. (>) The lower band in Lane 5 likely represents a faster migrating heterodimer band competed away by specific competitor (Lane 6) and overlaps a nonspecific band. As in Fig. 6 , the Panels A and B each represent a gel, respectively. Lys-TRE, where both heterodimers and homodimers formed. This approach of using nuclear extract to identify potential hetero-and/or homodimerization complexes could be useful in further studies to assess the relative roles of these complexes in the dominant negative activities of mutant receptors.
Expression of TRi81 Protein
In order to exclude the possibility that the expression of the transfected pSV2-h-TR,31 could be widely discrepant between the two cell types, immunocytochemistry, utilizing a monoclonal antibody directed at the amino terminus of WT h-TRf31, was performed. Figure 8 shows representative immunofluorescence and phase-contrast fields from HeLa and NIH3T3 cells and confirms that there is approximately equivalent receptor expression in both cell types. Furthermore, as demonstrated by Meier et al. (19) , the levels of nuclear h-TRf31 protein increased in parallel with the amount of WT or mutant pSV2-h-TRI3 transfected in HeLa cells, when using the same expression plasmid. It is thus reasonable to assume that this will also be the case for NIH3T3 cells.
DISCUSSION
The molecular mechanisms underlying the variable organ resistance within an individual and between kindreds with RTH, sharing identical mutations, have remained unresolved. We characterized positive TREs to investigate the role of cell type in modulating the dominant negative effect of mutant h-TR,31. Three different naturally occurring mutations from kindreds with RTH, which had previously been shown to have three distinct types of functional impairment on an idealized TRE (19, 20, 31) Almost all of the mutations that cause RTH cluster in two "hot spot" regions on either side of the dimerization domain (5) . This domain consists of nine heptad repeats, which are thought to be important for both dominant negative activity and transcription (36, 37) ; furthermore, a dimerization domain encompassing codons 281-300 has been defined by in vitro mutagenesis (38) (39) (40) (41) . Nagaya et al. (6) (22) were able to show, using several artificial TREs, preferential homodimerization with the S-mutant receptor, a powerful dominant negative receptor (42, 19) , and predominant heterodimerization with the GH receptor, which has compromised dominant negative function and was found in both normal individuals and in a patient with severe pituitary resistance to thyroid hormone (42, 43) . The latter finding with the GH receptor also supports one of our contentions that the greater the degree of heterodimerization versus homodimerization, the lesser the dominant negative potency of the receptor. The findings of Hao et al. (22) are also in contrast to those of Au-Fleigner et al. (23) , where mutational analysis of the ninth heptad repeat of the c-erbAal receptor demonstrated that this region was required for heterodimerization but not homodimerization and, furthermore, that the chick c-erbAal mutant with intact homodimerization lacked dominant negative activity. Our present study, however, suggests the possibility that both hetero-and homodimers in different amounts are capable of mediating the dominant negative effect depending on the contributions of cell type, mutation, and the TRE motif. Using h-TR(31 mutants in NIH3T3 cells on the Lys-TRE, homodimers were the predominant species; however, in HeLa cells, only heterodimers formed on the Lys-and ME-TREs, and this species may thus be responsible for dominant negative action in this cell.
All the studies to date have mostly focused on the TR-TRE relationships within one particular cell type. We present the first systematic study of mutant h-TRI3 interactions on natural TREs using two different cell types in order to assess the contribution of cell type to dominant negative potencies of mutant receptors. Although the cells used here may not necessarily be physiologically relevant, and the TREs used are not in the context of their full-length native promoters, certain preliminary conclusions can be drawn. Not only does the TRE motif and the isoform of the endogenously active receptor determine the degree of inhibition of a specific gene in RTH individuals as has been suggested by others (19, 20) , but we showed here that the cellular milieu in which a particular mutation operates could have important influences on the outcomes of these receptor-DNA interactions. Firstly, the magnitudes of the transcriptional activities on various natural TREs were different in the two cell types. Secondly, the dominant negative effect of a particular mutant receptor also differed between the two cell types when the identical TRE was used. Thirdly, the nature of the protein-protein complexes formed as assessed by gel-shift assays differed depending on the TRE and cell used. Fourthly, we have established that h-TR,Bl expression was equal in the two cells studied here, confirming that the differences in functional activities of the receptors observed herein were truly cell type specific. Thus, the cell type in which a mutant receptor is found could determine the relative amounts of hetero-and homodimers, and this, together with the nature of the mutation and the TRE motif, could influence the strength of the dominant negative action of mutant receptors and potentially contribute to the degree of organ resistance. Studies are underway to extend these observations to characterize the behavior of mutant h-TRfl on various natural TREs in the respective cell types in which they normally function. It is clear that more physiological approaches are required to further elucidate the mechanisms by which the dominant negative effect of mutant h-TR,31 correlates with the clinical phenotypes, and, to this end, we have developed a transgenic mouse model of RTH using the PV mutant receptor (44) .
